88 related articles for article (PubMed ID: 17348822)
1. Effects of IFN-alpha on alpha-fetoprotein expressions in hepatocellular carcinoma cells.
Yano H; Basaki Y; Oie S; Ogasawara S; Momosaki S; Akiba J; Nishida N; Kojiro S; Ishizaki H; Moriya F; Kuratomi K; Fukahori S; Kuwano M; Kojiro M
J Interferon Cytokine Res; 2007 Mar; 27(3):231-8. PubMed ID: 17348822
[TBL] [Abstract][Full Text] [Related]
2. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T
J Surg Res; 2012 Jan; 172(1):95-101. PubMed ID: 20851413
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
Yano H; Ogasawara S; Momosaki S; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Kuratomi K; Basaki Y; Oie S; Kuwano M; Kojiro M
Liver Int; 2006 Oct; 26(8):964-75. PubMed ID: 16953837
[TBL] [Abstract][Full Text] [Related]
4. The targeted expression of the human interleukin-2/interferon alpha2b fused gene in alpha-fetoprotein-expressing hepatocellular carcinoma cells.
He P; Tang ZY; Liu BB; Ye SL; Liu YK
J Cancer Res Clin Oncol; 1999; 125(2):77-82. PubMed ID: 10190313
[TBL] [Abstract][Full Text] [Related]
5. Regulation of gene expression by pegylated IFN-alpha2b and IFN-alpha2b in human peripheral blood mononuclear cells.
Brassard DL; Delorenzo MM; Cox S; Leaman DW; Sun Y; Ding W; Gavor S; Spond J; Goodsaid F; Bordens R; Grace MJ
J Interferon Cytokine Res; 2004 Aug; 24(8):455-69. PubMed ID: 15320959
[TBL] [Abstract][Full Text] [Related]
6. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
[TBL] [Abstract][Full Text] [Related]
7. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.
Vyas K; Brassard DL; DeLorenzo MM; Sun Y; Grace MJ; Borden EC; Leaman DW
J Immunother; 2003; 26(3):202-11. PubMed ID: 12806274
[TBL] [Abstract][Full Text] [Related]
8. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo.
Moriya F; Ogasawara S; Basaki Y; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Nishida N; Matsuoka K; Kojiro M; Kuwano M; Yano H
Int J Oncol; 2008 Oct; 33(4):647-55. PubMed ID: 18813777
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases.
Murphy D; Detjen KM; Welzel M; Wiedenmann B; Rosewicz S
Hepatology; 2001 Feb; 33(2):346-56. PubMed ID: 11172336
[TBL] [Abstract][Full Text] [Related]
11. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines.
Yano H; Iemura A; Haramaki M; Ogasawara S; Takayama A; Akiba J; Kojiro M
Hepatology; 1999 Jun; 29(6):1708-17. PubMed ID: 10347112
[TBL] [Abstract][Full Text] [Related]
12. Selective expression of nonsecreted interferon by an adenoviral vector confers antiproliferative and antiviral properties and causes reduction of tumor growth in nude mice.
Ahmed CM; Wills KN; Sugarman BJ; Johnson DE; Ramachandra M; Nagabhushan TL; Howe JA
J Interferon Cytokine Res; 2001 Jun; 21(6):399-408. PubMed ID: 11440637
[TBL] [Abstract][Full Text] [Related]
13. Effects of AFP gene silencing on apoptosis and proliferation of a hepatocellular carcinoma cell line.
Zhang L; He T; Cui H; Wang Y; Huang C; Han F
Discov Med; 2012 Aug; 14(75):115-24. PubMed ID: 22935208
[TBL] [Abstract][Full Text] [Related]
14. Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels.
Su Y; Cheng R; Zhang J; Qian J; Diao C; Ran J; Zhang H; Li L
Life Sci; 2015 Dec; 143():18-26. PubMed ID: 26518164
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
[TBL] [Abstract][Full Text] [Related]
16. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
17. [An experimental study on antiviral effects of IFN alpha].
Lu NF; Huang AL; Tang N; Zheng RQ; Lin H; Zhu YB; Wu Y; Tao P
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):892-6. PubMed ID: 16381632
[TBL] [Abstract][Full Text] [Related]
18. [Interferon-alpha upregulates thymidine phosphorylase expression via JAK-STAT transcriptional activation and mRNA stabilization in human hepatocellular carcinoma SMMC-7721 cells].
Xiao YS; Zhou J; Fan J; Sun QM; Zhao Y; Sun RX; Liu YK; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):444-7. PubMed ID: 19024520
[TBL] [Abstract][Full Text] [Related]
19. Induction of collagenase mRNA expression in dermal fibroblasts by IFN-alpha 2b and determination of the IFN-alpha 2b responsive element on 5'-flanking regions of collagenase promoter.
Ghahary A; Tredget EE; Shen Q
J Interferon Cytokine Res; 2001 Aug; 21(8):611-20. PubMed ID: 11559439
[TBL] [Abstract][Full Text] [Related]
20. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter.
Cai X; Zhou J; Chang Y; Sun X; Li P; Lin J
Cancer Lett; 2008 Jun; 264(1):71-82. PubMed ID: 18407409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
